FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, has now reached a significant milestone as the device has received CE mark and the sales has started. The...
Recent Posts
MedTech business is changing and getting more diverse. The technical complexity, different forms of digitalization and related regulatory requirements are increasing as we speak. And there is the...
Serres Group and Innokas Medical continue to strengthen their co-creation strategy and position in Scandinavia when Serres Group launches a new cooperation company in Sweden. Cubist IT AB is acting...
Innokas Medical, Olfactomics and BusinessOulu/OuluHealth are arranging Health Business Breakfast event in Oulu in the beginning of November. Welcome to listen, discuss and network with the...
Before introducing new medical devices to the market, there’s much more than simply coming up with an innovative idea, building it, and offering it to the masses. One clear rule in the medical field...
An innovation developed by Finnish startup company Olfactomics helps to improve the accuracy of cancer surgeries by allowing rapid, real-time analysis of biological gas mixtures during the surgery....
MedTech as a business is changing and getting more complex. For example, the technical complexity and regulatory requirements are something that are increasing as we speak. At the same time there is...
Innokas Medical entered into cooperation agreement with Finnish company GrainSense Oy in 2016. The mutual interest for the companies is to develop a long-term, fruitful co-creation partnership, where...
Across industries, the pace to introduce new products is increasing. This puts pressure to shortening the design and development cycles. Medical devices are no exception in this respect.
